Cancer and Metastasis Editorials and Commentaries

Articles (20 in this collection)

1. Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?

   Authors

   • Marek Z. Wojtukiewicz
   • Magda Pogorzelska
   • Barbara Politynska

   • Content type: COMMENTARY
   • Open Access
   • Published: 06 September 2022

   • Pages: 465 - 469

   

2. Obesity and cancer

   Authors

   • Emily J. Gallagher
   • Derek LeRoith

   • Content type: EDITORIAL
   • Published: 09 July 2022

   • Pages: 463 - 464

3. Targeting lipid metabolism in cancer: neuroblastoma

   Authors (first, second and last of 5)

   • Massimiliano Agostini
   • Gerry Melino
   • Nicolas G. Bazan

   • Content type: COMMENTARY
   • Open Access
   • Published: 10 June 2022

   • Pages: 255 - 260

   

4. Microbes and cancer: disease drivers, passengers, biomarkers, or therapeutics?

   Authors

   • Cynthia L. Sears

   • Content type: EDITORIAL
   • Published: 04 May 2022

   • Pages: 247 - 248

5. The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor

   Authors

   • Kendall C. Case
   • Michael W. Schmidtke
   • Miriam L. Greenberg

   • Content type: COMMENTARY
   • Published: 25 April 2022

   • Pages: 249 - 254

   

6. COVID-19 and cancer: start the resolution!

   Authors (first, second and last of 6)

   • Chantal Barksdale
   • Franciele C. Kipper
   • Dipak Panigrahy

   • Content type: COMMENTARY
   • Published: 21 February 2022

   • Pages: 1 - 15

   

7. Tumor metabolism: metabolic alterations and heterogeneity in cancer progression

   Authors

   • Anna Sebestyén

   • Content type: EditorialNotes
   • Published: 16 December 2021

   • Pages: 987 - 988

8. Where is Waldo? or find the platelet

   Authors

   • D. G. Menter

   • Content type: COMMENTARY
   • Open Access
   • Published: 30 September 2021

   • Pages: 649 - 655

   

9. Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration

   Authors (first, second and last of 6)

   • Nicolas G. Bazan
   • Madigan M. Reid
   • Ludmila Belayev

   • Content type: COMMENTARY
   • Open Access
   • Published: 14 September 2021

   • Pages: 643 - 647

   

10. Pancreatic cancer: why we must be optimistic?

    Authors

    • Philip A. Philip

    • Content type: EDITORIAL
    • Published: 06 October 2021

    • Pages: 659 - 660

    

11. Artificial intelligence—cogito, ergo sum

    Authors

    • Gregory W. Auner
    • Ehsan Majidi

    • Content type: COMMENTARY
    • Published: 24 May 2021

    • Pages: 375 - 376

12. Informing the new developments and future of cancer immunotherapy

    Authors

    • Atul Kumar
    • Courtney A. Swain
    • Lalita A. Shevde

    • Content type: ReviewPaper
    • Published: 18 May 2021

    • Pages: 549 - 562

    

13. Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects

    Authors

    • Richard P. Phipps
    • Patricia J. Sime
    • Connor R. Phipps

    • Content type: EDITORIAL
    • Published: 04 February 2021

    • Pages: 1 - 2

    

14. Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

    Authors (first, second and last of 7)

    • Gábor Tigyi
    • Mélanie A. Dacheux
    • Sue Chin Lee

    • Content type: COMMENTARY
    • Published: 17 January 2021

    • Pages: 3 - 5

15. A “New Radiation”—shining light on cancer

    Authors

    • Gregory W. Auner
    • Michelle A. Brusatori

    • Content type: Commentary
    • Published: 13 November 2020

    • Pages: 1019 - 1020

16. Metastasis is a highly stressful process

    Authors

    • Alejandro D. Campos
    • Sara M. Weis
    • David A. Cheresh

    • Content type: Commentary
    • Published: 06 November 2020

    • Pages: 1021 - 1022

    

17. A perspective on the early days of RAS research

    Authors

    • Robin A. Weiss

    • Content type: Editorial
    • Open Access
    • Published: 29 July 2020

    • Pages: 1023 - 1028

    

18. Role of linoleic acid-derived oxylipins in cancer

    Authors (first, second and last of 4)

    • Matthew L. Edin
    • Caroline Duval
    • Darryl C. Zeldin

    • Content type: Commentary
    • Published: 04 July 2020

    • Pages: 581 - 582

19. Caveolin and lipid domains–close companions in managing cellular pathways

    Authors

    • Jody V. Vykoukal
    • Johannes F. Fahrmann
    • Timothy C. Thompson

    • Content type: EditorialNotes
    • Published: 16 May 2020

    • Pages: 341 - 342

20. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?

    Authors (first, second and last of 9)

    • Dipak Panigrahy
    • Molly M. Gilligan
    • Bruce D. Hammock

    • Content type: Commentary
    • Published: 08 May 2020

    • Pages: 337 - 340